The rating assignment is based on SCHS’ generally solid operating performance, improved liquidity and commanding market position.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that SCHS’ balance sheet measures will remain stable and that its operating performance will grow stronger despite a modest dip related to an EMR installation.
More articles on healthcare finance:
Consumerism and RCM: 3 challenges posed by high deductibles & how to meet them
Why clinical documentation is the missing link to value-based reimbursement
DaVita’s net income falls 69% in Q2
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
